UBS Group
CELG

UBS Group’s Celgene Corp CELG Stock Holding History

UBS Group’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-110,000
Closed -$10.9M – 8838
2019
Q3 		$10.9M Sell
110,000
-100
-0.1% -$9.5K ﹤0.01% 1701
2019
Q2 		$10.2M Sell
110,100
-4,084,400
-97% -$388M ﹤0.01% 1742
2019
Q1 		$396M Buy
4,194,500
+3,762,300
+870% +$329M 0.16% 143
2018
Q4 		$27.7M Sell
432,200
-50,700
-10% -$3.74M 0.01% 874
2018
Q3 		$43.2M Sell
482,900
-317,500
-40% -$28.1M 0.02% 752
2018
Q2 		$63.6M Buy
800,400
+62,500
+8% +$5.19M 0.03% 545
2018
Q1 		$65.8M Buy
737,900
+200
+0% +$19.2K 0.03% 519
2017
Q4 		$77M Buy
737,700
+146,700
+25% +$16.6M 0.03% 500
2017
Q3 		$86.2M Buy
591,000
+419,400
+244% +$57.1M 0.04% 413
2017
Q2 		$22.3M Buy
171,600
+7,800
+5% +$956K 0.01% 987
2017
Q1 		$20.4M Sell
163,800
-112,391
-41% -$13.4M 0.01% 1019
2016
Q4 		$32M Buy
276,191
+87,900
+47% +$9.79M 0.02% 749
2016
Q3 		$19.7M Sell
188,291
-4,709
-2% -$510K 0.01% 992
2016
Q2 		$19M Buy
193,000
+104,600
+118% +$10.8M 0.01% 963
2016
Q1 		$8.85M Sell
88,400
-188,800
-68% -$19.4M 0.01% 1417
2015
Q4 		$33.2M Buy
277,200
+89,700
+48% +$10.4M 0.02% 689
2015
Q3 		$20.3M Sell
187,500
-68,726
-27% -$8.53M 0.01% 882
2015
Q2 		$29.7M Buy
256,226
+10,626
+4% +$1.21M 0.02% 751
2015
Q1 		$28.3M Sell
245,600
-50,300
-17% -$6.01M 0.02% 765
2014
Q4 		$33.1M Buy
+295,900
New +$31.2M 0.02% 706

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

UBS Group's CELG Position: Q4 2019 in Review

UBS Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,164,145 shares — an estimated $215M sold.

UBS Group first reported a position in CELG in Q4 2014 and held it in 20 quarters. The position peaked at $489M in Q2 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • UBS Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • UBS Group sold 2,164,145 Celgene Corp shares in Q4 2019, an estimated $215M.
  • UBS Group first reported a position in Celgene Corp in Q4 2014 and held it in 20 quarters.
  • UBS Group's Celgene Corp position peaked at $489M in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.